Clinical Trials
3 trialsNCT06790966 2026-04-06
VERSATILE-003
PDS Biotechnology Corp.
Phase 3 Active not recruiting
NCT03748134 2023-10-24
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Completed
NCT00382031 2013-10-15
Zalutumumab in Patients With Non-curable Head and Neck Cancer
Genmab
Phase 3 Completed